Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

CUSIP: 50127T109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,054,674
Total 13F shares
85,248,480
Share change
+1,461,857
Total reported value
$885,585,426
Put/Call ratio
70%
Price per share
$10.39
Number of holders
210
Value change
+$20,117,899
Number of buys
130
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2025

As of 31 Dec 2025, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by 210 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,248,480 shares. The largest 10 holders included BlackRock, Inc., BVF INC/IL, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, Prosight Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC. This page lists 210 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.